Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis

OBJECTIVE: The clinical course of multiple sclerosis (MS) is variable and largely unpredictable pointing to an urgent need for markers to monitor disease activity and progression. Recent evidence revealed that tissue transglutaminase (TG2) is altered in patient-derived monocytes. We hypothesize that...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurol Neuroimmunol Neuroinflamm
Asıl Yazarlar: Sestito, Claudia, Leurs, Cyra E., Steenwijk, Martijn D., Brevé, John J.P., Twisk, Jos W.R., Wilhelmus, Micha M.M., Drukarch, Benjamin, Teunissen, Charlotte E., van Dam, Anne-Marie, Killestein, Joep
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105890/
https://ncbi.nlm.nih.gov/pubmed/33906937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000998
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller